Diversified Healthcare Trust Common Shares of Beneficial Interest - DHC STOCK NEWS

Diversified Healthcare Trust (Nasdaq: DHC) has announced the sale of a 10% equity interest in its life science complex located in Boston for approximately $108 million. This transaction values the property at $1.7 billion after accounting for $620 million of existing debt. DHC intends to utilize the proceeds for capital expenditures, debt reduction, and general business purposes. The complex is nearly fully leased to Vertex Pharmaceuticals and reflects DHC's significant healthcare property portfolio valued at $6.8 billion.

Diversified Healthcare Trust (Nasdaq: DHC) held its 2022 Annual Meeting of Shareholders, where significant outcomes included the re-election of key trustees. Lisa Harris Jones received 80.0% support, John L. Harrington 72.3%, Jennifer F. Francis 97.7%, and Adam D. Portnoy 67.3%. Shareholders approved executive compensation with a favorable vote of 90.3% and ratified the appointment of Deloitte & Touche LLP as independent auditors with 99.4% support. DHC operates a diverse portfolio valued at approximately $6.8 billion across the healthcare sector.

Diversified Healthcare Trust (Nasdaq: DHC) announced that President and CEO Jennifer Francis will present at Nareit’s REITweek: 2022 Investor Conference on June 8, 2022, at 3:30 p.m. Eastern Time. A live audio webcast will be available on the company’s website, accessible 15 minutes before the presentation begins.

DHC is a REIT with approximately $6.8 billion in healthcare properties across 36 states and Washington, D.C., featuring over 27,500 senior living units and a life science portfolio of about nine million square feet.

Diversified Healthcare Trust (Nasdaq: DHC) announced that President Jennifer Francis and CFO Rick Siedel will meet investors at the 22nd Annual B. Riley Securities Institutional Investor Conference on May 25th, 2022, in Beverly Hills, CA. DHC is a real estate investment trust with approximately $6.8 billion in healthcare properties across 36 states and Washington, D.C. The company’s portfolio includes over 100 properties in life sciences and medical offices, totaling around nine million square feet, along with more than 27,500 senior living units.

AlerisLife (Nasdaq: ALR) announced that 53 of its communities were recognized by U.S. News and World Report in its inaugural "Best Senior Living" ratings, achieving the highest possible rating. This accolade highlights consumer satisfaction across various factors including community atmosphere, food quality, caregiving, and management. Notably, 46 of these rated communities are owned by Diversified Healthcare Trust (Nasdaq: DHC). The ratings are based on a survey of over 200,000 residents conducted between March 2021 and February 2022.

Diversified Healthcare Trust (Nasdaq: DHC) reported its Q1 2022 financial results, with net income of $240.4 million ($1.01 per share) and normalized FFO of $(21.9) million ($(0.09) per share). The company achieved a $327.5 million gain from a joint venture involving 10 Office Portfolio properties, adding $653 million in cash. Occupancy improved in the SHOP segment, reaching 73.0%. However, the Office Portfolio experienced declining occupancy rates, and DHC's liquidity ratio fell below the 1.5x requirement for incurring new debt. Cash and equivalents totaled approximately $1.5 billion.

Diversified Healthcare Trust (Nasdaq: DHC) has announced a quarterly dividend of $0.01 per common share, translating to $0.04 annually. This distribution will be paid on or about May 19, 2022 to shareholders on record as of April 25, 2022. DHC, with over $6.7 billion in healthcare properties across 36 states and Washington, D.C., focuses on diversified healthcare services, including over 100 life science and medical office properties and over 27,500 senior living units.

Diversified Healthcare Trust (Nasdaq: DHC) will release its first quarter 2022 financial results after market close on May 3, 2022. A conference call hosted by CEO Jennifer Francis and CFO Richard Siedel is scheduled for May 4, 2022, at 10:00 a.m. ET. Investors can participate by calling (877) 329-4297 or (412) 317-5435 for international calls. A replay of the call will be available until May 11, 2022. DHC owns over $6.7 billion in healthcare properties across 36 states and Washington, D.C., comprising more than 27,500 senior living units.

Diversified Healthcare Trust (Nasdaq: DHC) announced the election of David A. Pierce as an Independent Trustee, expanding its Board to seven members. The Board now comprises 71% independent members, with 29% women and 14% representing underrepresented communities. Mr. Pierce brings over 30 years of healthcare experience, previously serving as Executive VP at Boston Scientific. DHC invests in healthcare properties worth over $6.6 billion across 36 states and Washington, D.C., with a diverse portfolio including life sciences and senior living units.